Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the ...

Xeltis announced the completion of enrollment in its European Union (EU) pivotal trial for the aXess restorative vascular access ...

Anaconda Biomed S.L. announced that it named Trent Reutiman its new CEO. The company’s previous CEO Francois Salmon will n ...

Endologix LLC announced that John Liddicoat, MD, has been appointed as President and CEO, effective immediately. Matt Thompson, ...

Stryker announced a definitive agreement to acquire Inari Medical, Inc. for approximately $4.9 billion. Inari was founded in 201 ...

Viz.ai and Avicenna.AI recently announced that Viz.ai is integrating Avicenna.AI’s Cina-iPE and Cina-ASPECTS tools ...

December 19, 2024—Humacyte, Inc. announced that the FDA has granted full approval for the company’s Symvess—acellular tissue engineered vessel-tyod (ATEV)—for use in adults as a vascular conduit for ...

December 20, 2024—Merit Medical Systems, Inc. announced that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the FDA. The company stated that it can begin ...

Patient Presentation A male in his early 70s with a history of diabetes mellitus, hypertension, hyperlipidemia, and COVID-19 ...

Patient Presentation A man in his late 50s presented to the emergency department with 4 weeks of acute-onset, severely ...

December 19, 2024—Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the safety and clinical performance of the company’s Oscar ...